Global Brain Tumor Diagnosis and Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview:
Brain tumors are treated withsurgery, radiation therapy and chemotherapy. This report mainly focuses on brain tumor diagnosis and therapeutics market.
The Global Brain Tumor Diagnosis and Therapeutics Market Size was estimated at USD 2679.61 million in 2023 and is projected to reach USD 4695.54 million by 2029, exhibiting a CAGR of 9.80% during the forecast period.
This report provides a deep insight into the global Brain Tumor Diagnosis and Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Brain Tumor Diagnosis and Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Brain Tumor Diagnosis and Therapeutics market in any manner.
Global Brain Tumor Diagnosis and Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GE Healthcare
Hitachi
Philips Healthcare
Siemens Healthineers
Toshiba Corporation
Fujifilm Corporation
Shimadzu Corporation
Merck & Co.
AstraZeneca
Bristol Myer Squibb
Novartis
Roche Diagnostics
Market Segmentation (by Type)
MRI
CT Scan
Tissue Sampling
PET-CT Scan
Cerebral Arteriogram
Lumbar Puncture
Molecular Testing
EEG
Market Segmentation (by Application)
Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Brain Tumor Diagnosis and Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Brain tumors are treated withsurgery, radiation therapy and chemotherapy. This report mainly focuses on brain tumor diagnosis and therapeutics market.
The Global Brain Tumor Diagnosis and Therapeutics Market Size was estimated at USD 2679.61 million in 2023 and is projected to reach USD 4695.54 million by 2029, exhibiting a CAGR of 9.80% during the forecast period.
This report provides a deep insight into the global Brain Tumor Diagnosis and Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Brain Tumor Diagnosis and Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Brain Tumor Diagnosis and Therapeutics market in any manner.
Global Brain Tumor Diagnosis and Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GE Healthcare
Hitachi
Philips Healthcare
Siemens Healthineers
Toshiba Corporation
Fujifilm Corporation
Shimadzu Corporation
Merck & Co.
AstraZeneca
Bristol Myer Squibb
Novartis
Roche Diagnostics
Market Segmentation (by Type)
MRI
CT Scan
Tissue Sampling
PET-CT Scan
Cerebral Arteriogram
Lumbar Puncture
Molecular Testing
EEG
Market Segmentation (by Application)
Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Brain Tumor Diagnosis and Therapeutics Market
- Overview of the regional outlook of the Brain Tumor Diagnosis and Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Brain Tumor Diagnosis and Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Brain Tumor Diagnosis and Therapeutics
1.2 Key Market Segments
1.2.1 Brain Tumor Diagnosis and Therapeutics Segment by Type
1.2.2 Brain Tumor Diagnosis and Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Brain Tumor Diagnosis and Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Brain Tumor Diagnosis and Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Brain Tumor Diagnosis and Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Brain Tumor Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Brain Tumor Diagnosis and Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Brain Tumor Diagnosis and Therapeutics Sales Sites, Area Served, Product Type
3.6 Brain Tumor Diagnosis and Therapeutics Market Competitive Situation and Trends
3.6.1 Brain Tumor Diagnosis and Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Brain Tumor Diagnosis and Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Brain Tumor Diagnosis and Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Brain Tumor Diagnosis and Therapeutics Price by Type (2019-2024)
7 BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Brain Tumor Diagnosis and Therapeutics Market Sales by Application (2019-2024)
7.3 Global Brain Tumor Diagnosis and Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Brain Tumor Diagnosis and Therapeutics Sales Growth Rate by Application (2019-2024)
8 BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Brain Tumor Diagnosis and Therapeutics Sales by Region
8.1.1 Global Brain Tumor Diagnosis and Therapeutics Sales by Region
8.1.2 Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Brain Tumor Diagnosis and Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Brain Tumor Diagnosis and Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Brain Tumor Diagnosis and Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Brain Tumor Diagnosis and Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Brain Tumor Diagnosis and Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GE Healthcare
9.1.1 GE Healthcare Brain Tumor Diagnosis and Therapeutics Basic Information
9.1.2 GE Healthcare Brain Tumor Diagnosis and Therapeutics Product Overview
9.1.3 GE Healthcare Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.1.4 GE Healthcare Business Overview
9.1.5 GE Healthcare Brain Tumor Diagnosis and Therapeutics SWOT Analysis
9.1.6 GE Healthcare Recent Developments
9.2 Hitachi
9.2.1 Hitachi Brain Tumor Diagnosis and Therapeutics Basic Information
9.2.2 Hitachi Brain Tumor Diagnosis and Therapeutics Product Overview
9.2.3 Hitachi Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.2.4 Hitachi Business Overview
9.2.5 Hitachi Brain Tumor Diagnosis and Therapeutics SWOT Analysis
9.2.6 Hitachi Recent Developments
9.3 Philips Healthcare
9.3.1 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Basic Information
9.3.2 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Product Overview
9.3.3 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.3.4 Philips Healthcare Brain Tumor Diagnosis and Therapeutics SWOT Analysis
9.3.5 Philips Healthcare Business Overview
9.3.6 Philips Healthcare Recent Developments
9.4 Siemens Healthineers
9.4.1 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Basic Information
9.4.2 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Product Overview
9.4.3 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.4.4 Siemens Healthineers Business Overview
9.4.5 Siemens Healthineers Recent Developments
9.5 Toshiba Corporation
9.5.1 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Basic Information
9.5.2 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Product Overview
9.5.3 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.5.4 Toshiba Corporation Business Overview
9.5.5 Toshiba Corporation Recent Developments
9.6 Fujifilm Corporation
9.6.1 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Basic Information
9.6.2 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Product Overview
9.6.3 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.6.4 Fujifilm Corporation Business Overview
9.6.5 Fujifilm Corporation Recent Developments
9.7 Shimadzu Corporation
9.7.1 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Basic Information
9.7.2 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Product Overview
9.7.3 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.7.4 Shimadzu Corporation Business Overview
9.7.5 Shimadzu Corporation Recent Developments
9.8 Merck and Co.
9.8.1 Merck and Co. Brain Tumor Diagnosis and Therapeutics Basic Information
9.8.2 Merck and Co. Brain Tumor Diagnosis and Therapeutics Product Overview
9.8.3 Merck and Co. Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.8.4 Merck and Co. Business Overview
9.8.5 Merck and Co. Recent Developments
9.9 AstraZeneca
9.9.1 AstraZeneca Brain Tumor Diagnosis and Therapeutics Basic Information
9.9.2 AstraZeneca Brain Tumor Diagnosis and Therapeutics Product Overview
9.9.3 AstraZeneca Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.9.4 AstraZeneca Business Overview
9.9.5 AstraZeneca Recent Developments
9.10 Bristol Myer Squibb
9.10.1 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Basic Information
9.10.2 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Product Overview
9.10.3 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.10.4 Bristol Myer Squibb Business Overview
9.10.5 Bristol Myer Squibb Recent Developments
9.11 Novartis
9.11.1 Novartis Brain Tumor Diagnosis and Therapeutics Basic Information
9.11.2 Novartis Brain Tumor Diagnosis and Therapeutics Product Overview
9.11.3 Novartis Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.11.4 Novartis Business Overview
9.11.5 Novartis Recent Developments
9.12 Roche Diagnostics
9.12.1 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Basic Information
9.12.2 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Product Overview
9.12.3 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.12.4 Roche Diagnostics Business Overview
9.12.5 Roche Diagnostics Recent Developments
10 BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast
10.2 Global Brain Tumor Diagnosis and Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Region
10.2.4 South America Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Brain Tumor Diagnosis and Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Brain Tumor Diagnosis and Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Brain Tumor Diagnosis and Therapeutics by Type (2025-2030)
11.1.2 Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Brain Tumor Diagnosis and Therapeutics by Type (2025-2030)
11.2 Global Brain Tumor Diagnosis and Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Brain Tumor Diagnosis and Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Brain Tumor Diagnosis and Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Brain Tumor Diagnosis and Therapeutics
1.2 Key Market Segments
1.2.1 Brain Tumor Diagnosis and Therapeutics Segment by Type
1.2.2 Brain Tumor Diagnosis and Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Brain Tumor Diagnosis and Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Brain Tumor Diagnosis and Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Brain Tumor Diagnosis and Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Brain Tumor Diagnosis and Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Brain Tumor Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Brain Tumor Diagnosis and Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Brain Tumor Diagnosis and Therapeutics Sales Sites, Area Served, Product Type
3.6 Brain Tumor Diagnosis and Therapeutics Market Competitive Situation and Trends
3.6.1 Brain Tumor Diagnosis and Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Brain Tumor Diagnosis and Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Brain Tumor Diagnosis and Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Brain Tumor Diagnosis and Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Brain Tumor Diagnosis and Therapeutics Price by Type (2019-2024)
7 BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Brain Tumor Diagnosis and Therapeutics Market Sales by Application (2019-2024)
7.3 Global Brain Tumor Diagnosis and Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Brain Tumor Diagnosis and Therapeutics Sales Growth Rate by Application (2019-2024)
8 BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Brain Tumor Diagnosis and Therapeutics Sales by Region
8.1.1 Global Brain Tumor Diagnosis and Therapeutics Sales by Region
8.1.2 Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Brain Tumor Diagnosis and Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Brain Tumor Diagnosis and Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Brain Tumor Diagnosis and Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Brain Tumor Diagnosis and Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Brain Tumor Diagnosis and Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GE Healthcare
9.1.1 GE Healthcare Brain Tumor Diagnosis and Therapeutics Basic Information
9.1.2 GE Healthcare Brain Tumor Diagnosis and Therapeutics Product Overview
9.1.3 GE Healthcare Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.1.4 GE Healthcare Business Overview
9.1.5 GE Healthcare Brain Tumor Diagnosis and Therapeutics SWOT Analysis
9.1.6 GE Healthcare Recent Developments
9.2 Hitachi
9.2.1 Hitachi Brain Tumor Diagnosis and Therapeutics Basic Information
9.2.2 Hitachi Brain Tumor Diagnosis and Therapeutics Product Overview
9.2.3 Hitachi Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.2.4 Hitachi Business Overview
9.2.5 Hitachi Brain Tumor Diagnosis and Therapeutics SWOT Analysis
9.2.6 Hitachi Recent Developments
9.3 Philips Healthcare
9.3.1 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Basic Information
9.3.2 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Product Overview
9.3.3 Philips Healthcare Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.3.4 Philips Healthcare Brain Tumor Diagnosis and Therapeutics SWOT Analysis
9.3.5 Philips Healthcare Business Overview
9.3.6 Philips Healthcare Recent Developments
9.4 Siemens Healthineers
9.4.1 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Basic Information
9.4.2 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Product Overview
9.4.3 Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.4.4 Siemens Healthineers Business Overview
9.4.5 Siemens Healthineers Recent Developments
9.5 Toshiba Corporation
9.5.1 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Basic Information
9.5.2 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Product Overview
9.5.3 Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.5.4 Toshiba Corporation Business Overview
9.5.5 Toshiba Corporation Recent Developments
9.6 Fujifilm Corporation
9.6.1 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Basic Information
9.6.2 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Product Overview
9.6.3 Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.6.4 Fujifilm Corporation Business Overview
9.6.5 Fujifilm Corporation Recent Developments
9.7 Shimadzu Corporation
9.7.1 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Basic Information
9.7.2 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Product Overview
9.7.3 Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.7.4 Shimadzu Corporation Business Overview
9.7.5 Shimadzu Corporation Recent Developments
9.8 Merck and Co.
9.8.1 Merck and Co. Brain Tumor Diagnosis and Therapeutics Basic Information
9.8.2 Merck and Co. Brain Tumor Diagnosis and Therapeutics Product Overview
9.8.3 Merck and Co. Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.8.4 Merck and Co. Business Overview
9.8.5 Merck and Co. Recent Developments
9.9 AstraZeneca
9.9.1 AstraZeneca Brain Tumor Diagnosis and Therapeutics Basic Information
9.9.2 AstraZeneca Brain Tumor Diagnosis and Therapeutics Product Overview
9.9.3 AstraZeneca Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.9.4 AstraZeneca Business Overview
9.9.5 AstraZeneca Recent Developments
9.10 Bristol Myer Squibb
9.10.1 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Basic Information
9.10.2 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Product Overview
9.10.3 Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.10.4 Bristol Myer Squibb Business Overview
9.10.5 Bristol Myer Squibb Recent Developments
9.11 Novartis
9.11.1 Novartis Brain Tumor Diagnosis and Therapeutics Basic Information
9.11.2 Novartis Brain Tumor Diagnosis and Therapeutics Product Overview
9.11.3 Novartis Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.11.4 Novartis Business Overview
9.11.5 Novartis Recent Developments
9.12 Roche Diagnostics
9.12.1 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Basic Information
9.12.2 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Product Overview
9.12.3 Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Product Market Performance
9.12.4 Roche Diagnostics Business Overview
9.12.5 Roche Diagnostics Recent Developments
10 BRAIN TUMOR DIAGNOSIS AND THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast
10.2 Global Brain Tumor Diagnosis and Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Region
10.2.4 South America Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Brain Tumor Diagnosis and Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Brain Tumor Diagnosis and Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Brain Tumor Diagnosis and Therapeutics by Type (2025-2030)
11.1.2 Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Brain Tumor Diagnosis and Therapeutics by Type (2025-2030)
11.2 Global Brain Tumor Diagnosis and Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Brain Tumor Diagnosis and Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Brain Tumor Diagnosis and Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Brain Tumor Diagnosis and Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Brain Tumor Diagnosis and Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Brain Tumor Diagnosis and Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Brain Tumor Diagnosis and Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnosis and Therapeutics as of 2022)
Table 10. Global Market Brain Tumor Diagnosis and Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Brain Tumor Diagnosis and Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Brain Tumor Diagnosis and Therapeutics Product Type
Table 13. Global Brain Tumor Diagnosis and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Brain Tumor Diagnosis and Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Brain Tumor Diagnosis and Therapeutics Market Challenges
Table 22. Global Brain Tumor Diagnosis and Therapeutics Sales by Type (K Units)
Table 23. Global Brain Tumor Diagnosis and Therapeutics Market Size by Type (M USD)
Table 24. Global Brain Tumor Diagnosis and Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Brain Tumor Diagnosis and Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Brain Tumor Diagnosis and Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Brain Tumor Diagnosis and Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Brain Tumor Diagnosis and Therapeutics Sales (K Units) by Application
Table 30. Global Brain Tumor Diagnosis and Therapeutics Market Size by Application
Table 31. Global Brain Tumor Diagnosis and Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Brain Tumor Diagnosis and Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Brain Tumor Diagnosis and Therapeutics Market Share by Application (2019-2024)
Table 35. Global Brain Tumor Diagnosis and Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Brain Tumor Diagnosis and Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Brain Tumor Diagnosis and Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Brain Tumor Diagnosis and Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Brain Tumor Diagnosis and Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Brain Tumor Diagnosis and Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. GE Healthcare Brain Tumor Diagnosis and Therapeutics Basic Information
Table 44. GE Healthcare Brain Tumor Diagnosis and Therapeutics Product Overview
Table 45. GE Healthcare Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. GE Healthcare Business Overview
Table 47. GE Healthcare Brain Tumor Diagnosis and Therapeutics SWOT Analysis
Table 48. GE Healthcare Recent Developments
Table 49. Hitachi Brain Tumor Diagnosis and Therapeutics Basic Information
Table 50. Hitachi Brain Tumor Diagnosis and Therapeutics Product Overview
Table 51. Hitachi Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Hitachi Business Overview
Table 53. Hitachi Brain Tumor Diagnosis and Therapeutics SWOT Analysis
Table 54. Hitachi Recent Developments
Table 55. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Basic Information
Table 56. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Product Overview
Table 57. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Philips Healthcare Brain Tumor Diagnosis and Therapeutics SWOT Analysis
Table 59. Philips Healthcare Business Overview
Table 60. Philips Healthcare Recent Developments
Table 61. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Basic Information
Table 62. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Product Overview
Table 63. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Siemens Healthineers Business Overview
Table 65. Siemens Healthineers Recent Developments
Table 66. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Basic Information
Table 67. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Product Overview
Table 68. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Toshiba Corporation Business Overview
Table 70. Toshiba Corporation Recent Developments
Table 71. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Basic Information
Table 72. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Product Overview
Table 73. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Fujifilm Corporation Business Overview
Table 75. Fujifilm Corporation Recent Developments
Table 76. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Basic Information
Table 77. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Product Overview
Table 78. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Shimadzu Corporation Business Overview
Table 80. Shimadzu Corporation Recent Developments
Table 81. Merck and Co. Brain Tumor Diagnosis and Therapeutics Basic Information
Table 82. Merck and Co. Brain Tumor Diagnosis and Therapeutics Product Overview
Table 83. Merck and Co. Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Merck and Co. Business Overview
Table 85. Merck and Co. Recent Developments
Table 86. AstraZeneca Brain Tumor Diagnosis and Therapeutics Basic Information
Table 87. AstraZeneca Brain Tumor Diagnosis and Therapeutics Product Overview
Table 88. AstraZeneca Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Recent Developments
Table 91. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Basic Information
Table 92. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Product Overview
Table 93. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Bristol Myer Squibb Business Overview
Table 95. Bristol Myer Squibb Recent Developments
Table 96. Novartis Brain Tumor Diagnosis and Therapeutics Basic Information
Table 97. Novartis Brain Tumor Diagnosis and Therapeutics Product Overview
Table 98. Novartis Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Novartis Business Overview
Table 100. Novartis Recent Developments
Table 101. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Basic Information
Table 102. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Product Overview
Table 103. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Roche Diagnostics Business Overview
Table 105. Roche Diagnostics Recent Developments
Table 106. Global Brain Tumor Diagnosis and Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Brain Tumor Diagnosis and Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Brain Tumor Diagnosis and Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Brain Tumor Diagnosis and Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Brain Tumor Diagnosis and Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Brain Tumor Diagnosis and Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Brain Tumor Diagnosis and Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Brain Tumor Diagnosis and Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Brain Tumor Diagnosis and Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Brain Tumor Diagnosis and Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Brain Tumor Diagnosis and Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Brain Tumor Diagnosis and Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Diagnosis and Therapeutics as of 2022)
Table 10. Global Market Brain Tumor Diagnosis and Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Brain Tumor Diagnosis and Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Brain Tumor Diagnosis and Therapeutics Product Type
Table 13. Global Brain Tumor Diagnosis and Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Brain Tumor Diagnosis and Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Brain Tumor Diagnosis and Therapeutics Market Challenges
Table 22. Global Brain Tumor Diagnosis and Therapeutics Sales by Type (K Units)
Table 23. Global Brain Tumor Diagnosis and Therapeutics Market Size by Type (M USD)
Table 24. Global Brain Tumor Diagnosis and Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Brain Tumor Diagnosis and Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Brain Tumor Diagnosis and Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Brain Tumor Diagnosis and Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Brain Tumor Diagnosis and Therapeutics Sales (K Units) by Application
Table 30. Global Brain Tumor Diagnosis and Therapeutics Market Size by Application
Table 31. Global Brain Tumor Diagnosis and Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Brain Tumor Diagnosis and Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Brain Tumor Diagnosis and Therapeutics Market Share by Application (2019-2024)
Table 35. Global Brain Tumor Diagnosis and Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Brain Tumor Diagnosis and Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Brain Tumor Diagnosis and Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Brain Tumor Diagnosis and Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Brain Tumor Diagnosis and Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Brain Tumor Diagnosis and Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. GE Healthcare Brain Tumor Diagnosis and Therapeutics Basic Information
Table 44. GE Healthcare Brain Tumor Diagnosis and Therapeutics Product Overview
Table 45. GE Healthcare Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. GE Healthcare Business Overview
Table 47. GE Healthcare Brain Tumor Diagnosis and Therapeutics SWOT Analysis
Table 48. GE Healthcare Recent Developments
Table 49. Hitachi Brain Tumor Diagnosis and Therapeutics Basic Information
Table 50. Hitachi Brain Tumor Diagnosis and Therapeutics Product Overview
Table 51. Hitachi Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Hitachi Business Overview
Table 53. Hitachi Brain Tumor Diagnosis and Therapeutics SWOT Analysis
Table 54. Hitachi Recent Developments
Table 55. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Basic Information
Table 56. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Product Overview
Table 57. Philips Healthcare Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Philips Healthcare Brain Tumor Diagnosis and Therapeutics SWOT Analysis
Table 59. Philips Healthcare Business Overview
Table 60. Philips Healthcare Recent Developments
Table 61. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Basic Information
Table 62. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Product Overview
Table 63. Siemens Healthineers Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Siemens Healthineers Business Overview
Table 65. Siemens Healthineers Recent Developments
Table 66. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Basic Information
Table 67. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Product Overview
Table 68. Toshiba Corporation Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Toshiba Corporation Business Overview
Table 70. Toshiba Corporation Recent Developments
Table 71. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Basic Information
Table 72. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Product Overview
Table 73. Fujifilm Corporation Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Fujifilm Corporation Business Overview
Table 75. Fujifilm Corporation Recent Developments
Table 76. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Basic Information
Table 77. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Product Overview
Table 78. Shimadzu Corporation Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Shimadzu Corporation Business Overview
Table 80. Shimadzu Corporation Recent Developments
Table 81. Merck and Co. Brain Tumor Diagnosis and Therapeutics Basic Information
Table 82. Merck and Co. Brain Tumor Diagnosis and Therapeutics Product Overview
Table 83. Merck and Co. Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Merck and Co. Business Overview
Table 85. Merck and Co. Recent Developments
Table 86. AstraZeneca Brain Tumor Diagnosis and Therapeutics Basic Information
Table 87. AstraZeneca Brain Tumor Diagnosis and Therapeutics Product Overview
Table 88. AstraZeneca Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. AstraZeneca Business Overview
Table 90. AstraZeneca Recent Developments
Table 91. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Basic Information
Table 92. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Product Overview
Table 93. Bristol Myer Squibb Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Bristol Myer Squibb Business Overview
Table 95. Bristol Myer Squibb Recent Developments
Table 96. Novartis Brain Tumor Diagnosis and Therapeutics Basic Information
Table 97. Novartis Brain Tumor Diagnosis and Therapeutics Product Overview
Table 98. Novartis Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Novartis Business Overview
Table 100. Novartis Recent Developments
Table 101. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Basic Information
Table 102. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Product Overview
Table 103. Roche Diagnostics Brain Tumor Diagnosis and Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Roche Diagnostics Business Overview
Table 105. Roche Diagnostics Recent Developments
Table 106. Global Brain Tumor Diagnosis and Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Brain Tumor Diagnosis and Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Brain Tumor Diagnosis and Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Brain Tumor Diagnosis and Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Brain Tumor Diagnosis and Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Brain Tumor Diagnosis and Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Brain Tumor Diagnosis and Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Brain Tumor Diagnosis and Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Brain Tumor Diagnosis and Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Brain Tumor Diagnosis and Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Brain Tumor Diagnosis and Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Brain Tumor Diagnosis and Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Brain Tumor Diagnosis and Therapeutics Market Size by Country (M USD)
Figure 11. Brain Tumor Diagnosis and Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Brain Tumor Diagnosis and Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Brain Tumor Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Brain Tumor Diagnosis and Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Brain Tumor Diagnosis and Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Brain Tumor Diagnosis and Therapeutics Market Share by Type
Figure 18. Sales Market Share of Brain Tumor Diagnosis and Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Brain Tumor Diagnosis and Therapeutics by Type in 2023
Figure 20. Market Size Share of Brain Tumor Diagnosis and Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Brain Tumor Diagnosis and Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Brain Tumor Diagnosis and Therapeutics Market Share by Application
Figure 24. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Brain Tumor Diagnosis and Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Brain Tumor Diagnosis and Therapeutics Market Share by Application in 2023
Figure 28. Global Brain Tumor Diagnosis and Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Brain Tumor Diagnosis and Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Brain Tumor Diagnosis and Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Brain Tumor Diagnosis and Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Brain Tumor Diagnosis and Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Brain Tumor Diagnosis and Therapeutics Sales Market Share by Region in 2023
Figure 44. China Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Brain Tumor Diagnosis and Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Brain Tumor Diagnosis and Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Brain Tumor Diagnosis and Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Brain Tumor Diagnosis and Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Brain Tumor Diagnosis and Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Brain Tumor Diagnosis and Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Brain Tumor Diagnosis and Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Brain Tumor Diagnosis and Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Brain Tumor Diagnosis and Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Brain Tumor Diagnosis and Therapeutics Market Size by Country (M USD)
Figure 11. Brain Tumor Diagnosis and Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Brain Tumor Diagnosis and Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Brain Tumor Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Brain Tumor Diagnosis and Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Brain Tumor Diagnosis and Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Brain Tumor Diagnosis and Therapeutics Market Share by Type
Figure 18. Sales Market Share of Brain Tumor Diagnosis and Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Brain Tumor Diagnosis and Therapeutics by Type in 2023
Figure 20. Market Size Share of Brain Tumor Diagnosis and Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Brain Tumor Diagnosis and Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Brain Tumor Diagnosis and Therapeutics Market Share by Application
Figure 24. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Brain Tumor Diagnosis and Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Brain Tumor Diagnosis and Therapeutics Market Share by Application in 2023
Figure 28. Global Brain Tumor Diagnosis and Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Brain Tumor Diagnosis and Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Brain Tumor Diagnosis and Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Brain Tumor Diagnosis and Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Brain Tumor Diagnosis and Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Brain Tumor Diagnosis and Therapeutics Sales Market Share by Region in 2023
Figure 44. China Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Brain Tumor Diagnosis and Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Brain Tumor Diagnosis and Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Brain Tumor Diagnosis and Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Brain Tumor Diagnosis and Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Brain Tumor Diagnosis and Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Brain Tumor Diagnosis and Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Brain Tumor Diagnosis and Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Brain Tumor Diagnosis and Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Brain Tumor Diagnosis and Therapeutics Market Share Forecast by Application (2025-2030)
